✦ LIBER ✦

Book Reviews: Evidence-based Medicine: How to Practice and Teach EBM

✍ Scribed by Eva Fung

Book ID: 114464887
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 43 KB
Volume: 5
Category: Article
ISSN: 1090-3798
DOI: 10.1053/ejpn.2000.0404

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

How doctors practice evidence-based medi

How doctors practice evidence-based medicine

✍ Yun-Chieh Lu; Ying-Chun Li 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

How to teach evidence-based medicine to

How to teach evidence-based medicine to teachers: reflections from a workshop experience

✍ Mchammad Hassan Murad; Victor M. Montori; Regina Kunz; Luz M. Letelier; Sheri A. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Sackett DL, Straus SE, Richardson WS, Ro

Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB, ,Evidence Based Medicine: How to practice and teach EBM 2nd ed (2000) Churchill Livingstone 0443 062 40 4.

✍ Andrew Vitiello 📂 Article 📅 2001 🏛 Elsevier Science ⚖ 253 KB

Evidence-Based Medicine and Women: Do th

Evidence-Based Medicine and Women: Do the Principles and Practice of EBM Further Women's Health?

✍ Wendy Rogers 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

S.E. Straus, W.S. Richardson, P. Glaszio

S.E. Straus, W.S. Richardson, P. Glasziou, R.B. Haynes, ,Evidence-Based Medicine: How to Practice and Teach EBM 3rd ed. (2005) Churchill Livingstone, Elsevier,Edinburgh 315 pp., Price $75.00 (AUD), ISBN: 044307445.

✍ Toni G. McCallum Pardey 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Response to Montgomery/Turkstra Re: Rati

Response to Montgomery/Turkstra Re: Rational therapy: Defense against evidence based medicine (EBM)

✍ Norman C. Reynolds Jr.; Robert B. Slocum 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Although we are sympathetic to Reynolds and Slocum's concerns, 1 their editorial errs on several points. The authors cite deference to regulatory (presumably Food and Drug Administration) approval as a constraint. The FDA has long recognized broad physician discretion in using FDAapproved drugs or d